Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Togashi

Showing results (21-30 of 156) with videos related to

Pageof 16
Sort By:
Anticancer Research|April 12, 2015
Afatinib is especially effective against non-small cell lung cancer carrying an EGFR exon 19 deletionEri Banno, Yosuke Togashi, Yoshihisa Kobayashi, et al.
Oncology Letters|February 22, 2013
Continuous morphine infusion for end-stage lung cancer patientsYoung Hak Kim, Chiyuki Okuda, Yuichi Sakamori, et al.
Lung Cancer (Amsterdam, Netherlands)|November 9, 2015
MET gene exon 14 deletion created using the CRISPR/Cas9 system enhances cellular growth and sensitivity to a MET inhibitorYosuke Togashi, Hiroshi Mizuuchi, Shuta Tomida, et al.
Journal of the American Chemical Society|November 4, 2025
Optogenetic Cancer Therapy Using the Light-Driven Outward Proton Pump Rhodopsin Archaerhodopsin-3 (AR3)Shin Nakao, Keiichi Kojima, Keita Sato, et al.
International Journal of Clinical Oncology|December 1, 2010
Pulmonary embolism due to internal jugular vein thrombosis in a patient with non-small cell lung cancer receiving bevacizumabYosuke Togashi, Young Hak Kim, Katsuhiro Masago, et al.
Oncology Letters|August 7, 2012
EGFR mutation: Significance as a stratification factor in the era of molecular-targeted therapyYoung Hak Kim, Katsuhiro Masago, Yosuke Togashi, et al.
Lung Cancer (Amsterdam, Netherlands)|May 15, 2012
Successful erlotinib rechallenge for leptomeningeal metastases of lung adenocarcinoma after erlotinib-induced interstitial lung disease: a case report and review of the literatureYosuke Togashi, Katsuhiro Masago, Yasuhiro Hamatani, et al.
Japanese Journal of Clinical Oncology|January 19, 2011
Long-term survival in a patient with small-cell lung cancer undergoing hemodialysis who received multiple courses of chemotherapyYosuke Togashi, Young Hak Kim, Katsuhiro Masago, et al.
Internal Medicine (Tokyo, Japan)|March 10, 2015
Multiple primary malignancies in patients with non-small cell lung cancerShiro Fujita, Katsuhiro Masago, Jumpei Takeshita, et al.
Biochemical and Biophysical Research Communications|January 28, 2015
Inter- and intra-tumor profiling of multi-regional colon cancer and metastasisAkihiro Kogita, Yasumasa Yoshioka, Kazuko Sakai, et al.
Pageof 16

Showing results (21-30 of 156) with videos related to

Sort By:
Pageof 16
Anticancer Research|April 12, 2015
Afatinib is especially effective against non-small cell lung cancer carrying an EGFR exon 19 deletionEri Banno, Yosuke Togashi, Yoshihisa Kobayashi, et al.
Oncology Letters|February 22, 2013
Continuous morphine infusion for end-stage lung cancer patientsYoung Hak Kim, Chiyuki Okuda, Yuichi Sakamori, et al.
Lung Cancer (Amsterdam, Netherlands)|November 9, 2015
MET gene exon 14 deletion created using the CRISPR/Cas9 system enhances cellular growth and sensitivity to a MET inhibitorYosuke Togashi, Hiroshi Mizuuchi, Shuta Tomida, et al.
Journal of the American Chemical Society|November 4, 2025
Optogenetic Cancer Therapy Using the Light-Driven Outward Proton Pump Rhodopsin Archaerhodopsin-3 (AR3)Shin Nakao, Keiichi Kojima, Keita Sato, et al.
International Journal of Clinical Oncology|December 1, 2010
Pulmonary embolism due to internal jugular vein thrombosis in a patient with non-small cell lung cancer receiving bevacizumabYosuke Togashi, Young Hak Kim, Katsuhiro Masago, et al.
Oncology Letters|August 7, 2012
EGFR mutation: Significance as a stratification factor in the era of molecular-targeted therapyYoung Hak Kim, Katsuhiro Masago, Yosuke Togashi, et al.
Lung Cancer (Amsterdam, Netherlands)|May 15, 2012
Successful erlotinib rechallenge for leptomeningeal metastases of lung adenocarcinoma after erlotinib-induced interstitial lung disease: a case report and review of the literatureYosuke Togashi, Katsuhiro Masago, Yasuhiro Hamatani, et al.
Japanese Journal of Clinical Oncology|January 19, 2011
Long-term survival in a patient with small-cell lung cancer undergoing hemodialysis who received multiple courses of chemotherapyYosuke Togashi, Young Hak Kim, Katsuhiro Masago, et al.
Internal Medicine (Tokyo, Japan)|March 10, 2015
Multiple primary malignancies in patients with non-small cell lung cancerShiro Fujita, Katsuhiro Masago, Jumpei Takeshita, et al.
Biochemical and Biophysical Research Communications|January 28, 2015
Inter- and intra-tumor profiling of multi-regional colon cancer and metastasisAkihiro Kogita, Yasumasa Yoshioka, Kazuko Sakai, et al.
Pageof 16